CrushSCI.com
308.2Average days
325Median days
29Fastest days
696Longest days
3282025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

85 days

Collaborative functionality between three types of inflammation in idiopathic pulmonary fibrosis

Authors
Thomas Fabre; Thomas A. Wynn; Kevin M. HartShow moreShow less
Affiliations
1. Pfizer, Cambridge, USAShow moreShow less
Source PDF DOI Publisher page
331 days

Progenitor T cells drive chronic pulmonary type 2 inflammation

Authors
Radomir Kratchmarov; Xiaojiong Jia; Jun Nagai; Gaspar A. Pacheco; Alexander Perniss; Madeleine R. Bell; Ersin Gül; Thornton W. Thompson; Hiroaki Hayashi; Shahab Saghaei; Caitlin Wong; Madeline M. Hastings; Kinan Alhallak; Juying Lai; Chunli Feng; Lora Bankova; Duane R. Wesemann; Jakob von Moltke; Joshua A. Boyce; Patrick J. BrennanShow moreShow less
Affiliations
1. Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA; 2. Division of Allergy and Clinical Immunology & Division of Genetics, Department of Medicine, Brigham and Women’s Hospital Boston, Harvard Medical School, Boston, USA; 3. The Broad Institute of MIT and Harvard, Cambridge, USA; 4. The Ragon Institute of MGH, MIT and Harvard, Cambridge, USA; 5. Department of Immunology, University of Washington School of Medicine, Seattle, USAShow moreShow less
Source PDF DOI Publisher page
152 days

Hallmarks of the multidimensional immune response to trauma in humans

Authors
Markus Huber-Lang; Tianmeng Chen; Rebecca Halbgebauer; Timothy BilliarShow moreShow less
Affiliations
1. Institute of Clinical and Experimental Trauma Immunology, Ulm University Medical Center, Ulm, Germany; 2. Department of Surgery, University of Pittsburgh, Pittsburgh, USAShow moreShow less
Source PDF DOI Publisher page
120 days

Potent type-specific de novo antibodies complement broadly reactive imprinted antibodies in immune responses to SARS-CoV-2 variants

Authors
Timothy S. Johnston; Shuk Hang Li; Mark M. Painter; Divya Swaminathan; Reilly K. Atkinson; Bernadeta Dadonaite; Shuishu Wang; Naomi R. Douek; Lucas Kampman; Robin Schlesinger; Rachel Kazmierski; Bob C. Lin; Leonid A. Serebryannyy; Haijuan Du; Amy R. Henry; Sarah C. Smith; Farida Laboune; I-Ting Teng; Lingshu Wang; Nicole A. Doria-Rose; Chaim A. Schramm; Theodore C. Pierson; Tongqing Zhou; Jesse D. Bloom; E. John Wherry; Scott E. Hensley; Daniel C. DouekShow moreShow less
Affiliations
1. Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA; 2. Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA; 3. Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA; 4. Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA; 5. Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, USA; 6. Howard Hughes Medical Institute, Seattle, USAShow moreShow less
Source PDF DOI Publisher page
447 days

Peyer’s patch M cells organize an epithelial niche that sustains group 3 innate lymphoid cells and IL-22

Authors
Wang H. J. Cao; Yue You; Nancy Wang; M. Zeeshan Chaudhry; Huiyang Yu; Peter T. Bell; Ellesandra C. Noye; Renae Denman; Byungchul Lee; Abbey Waddington; Junpeng Ye; Jaring Schreuder; Qiutong Huang; Julie Tellier; Sophie Curio; James Santiago; Daniela Amann-Zalcenstein; Nicolas Jacquelot; Peter Hickey; Stephen L. Nutt; Cyril Seillet; Philip M. Hansbro; Verena C. Wimmer; Richard A. Strugnell; Zewen Kelvin Tuong; Matthew E. Ritchie; Gabrielle T. BelzShow moreShow less
Affiliations
1. The University of Queensland Frazer Institute, University of Queensland, Woolloongabba, Australia; 2. Walter and Eliza Hall Institute of Medical Research, Parkville, Australia; 3. Department of Medical Biology, University of Melbourne, Parkville, Australia; 4. Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; 5. Department of Biochemistry & Molecular Biology; Department of Microbiology, Immunology & Infectious Diseases; Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases, Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada; 6. Department of Immunology, University of Monash, Melbourne, Australia; 7. Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; 8. Ian Frazer Centre for Children’s Immunotherapy Research, Child Health Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, AustraliaShow moreShow less
Source PDF DOI Publisher page
341 days

Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn’s disease

Authors
Simon Koplev; Osheen Sharma; Simon Woelfel; Ni Huang; Mathilde Pohin; Adrian Feile; Maria Warschinke; Mikel Rezola Artero; Sharujan Suthakaran; Ioannis Sarropoulos; J. Patrick Pett; Julia Nyman; Tom Thomas; Duy Pham; Bin Li; Moustafa Attar; Julia Pakpoor; Kate Milosevic-Hutton; Alistair Easton; Matt Butler; James Dunford; Martin Philpott; Mark Coles; Christopher D. Buckley; Calliope Dendrou; Khalid Shamiyah; Lorenz Kretschmer; Lisa Dratva; Fadi Issa; Joanna Hester; Jens Rittscher; Alissa Walsh; Simon P. Travis; Fränze Progatzky; Lukas W. Unger; Mark Bignell; Katherine Baker; Bruce George; Hussein Al-Mossawi; Paul Klenerman; Alexander S. Mosig; Udo Oppermann; Sarah A. Teichmann; Fiona M. Powrie; Matthias FriedrichShow moreShow less
Affiliations
1. Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK; 2. Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden; 3. Translational Gastroenterology and Liver Unit, University of Oxford, Oxford, UK; 4. Wellcome Sanger Institute, Cambridge, UK; 5. ImmunoConcept University of Bordeaux, Immunology and Immunogenetic Unit University Hospital of Bordeaux, Bordeaux, France; 6. Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK; 7. Institute of Biochemistry II, Jena University Hospital, Jena, Germany; 8. Big Data Institute/Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK; 9. NIHR Oxford Biomedical Research Centre Oxford, Oxford, UK; 10. Department of Oncology, University of Oxford, Oxford, UK; 11. UCB Pharma, Slough, UK; 12. Botnar Institute, University of Oxford, Oxford, UK; 13. Oxford Translational Myeloma Centre, Botnar Research Centre, University of Oxford, Oxford, UK; 14. Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; 15. Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; 16. CAMS Oxford Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, University of Oxford, Oxford, UK; 17. Institute of Biomedical Engineering (IBME), Department of Engineering Science, University of Oxford, Oxford, UK; 18. Ludwig Institute for Cancer Research (Oxford Branch), University of Oxford, Oxford, UK; 19. Department of Colorectal Surgery, Oxford University Hospitals, Oxford, UK; 20. Peter Medawar Building, South Parks Rd, University of Oxford, Oxford, UK; 21. Pandemic Sciences Institute, University of Oxford, Oxford, UKShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.